Latest It Compliance News

EVE Health Group’s subsidiary Nextract has inked a pivotal two-year agreement with TeleDocs Clinic, enabling nationwide online prescribing of its upcoming erectile dysfunction and dysmenorrhea products ahead of regulatory approval.

Talga Group’s Nunasvaara South graphite mine zoning plan process shifts to regional government after local deadline missed, advancing a key step in Sweden’s battery materials push.

Bubs Australia has submitted critical clinical trial data to the US FDA, marking a pivotal step toward permanent approval for its infant formulas in the US market.

Marimaca Copper has successfully closed the second tranche of a US$17.7 million private placement, bolstering funds to advance its flagship copper project in Chile. This capital injection marks a significant step in progressing the Marimaca Copper Project’s feasibility and exploration activities.

VBX Limited is set to raise $10 million through an initial public offering to fund the development of its Wuudagu Bauxite Project in Western Australia, supported by a positive pre-feasibility study and strong market fundamentals driven by China’s growing aluminium demand.

Macarthur Minerals has clarified key details regarding its recent convertible note funding, confirming the counterparty is an independent entity and highlighting the need for shareholder approval before issuing shares on conversion.

Patronus Resources has clarified that its recent share price jump stems from a third-party research report rather than undisclosed company news, following an ASX inquiry. The company also confirmed the recent release of exploration results from its Western Australian gold projects.

Enlitic, Inc. has launched a A$10 million placement alongside an offer of 125 million unquoted options, aiming to fuel growth in its AI-driven healthcare technology business. The move underscores both funding ambitions and the complex risks tied to AI adoption and market dynamics.

Cobre Limited has announced a fully underwritten loyalty options offer to raise approximately $1.18 million, offering eligible shareholders one new option for every three shares held at $0.008 each. The new options carry an exercise price of $0.066 and expire in November 2028.

WCM Global Growth Limited has renewed its on-market share buy-back program for 12 months, signaling ongoing confidence in its capital management strategy amid evolving market conditions.

New World Resources has successfully completed a placement of 32 million shares at $0.02 each to its board and senior management, following shareholder approval. This move subtly reshapes the company’s capital structure ahead of its copper and base metals projects in the US.

AdAlta Limited has successfully placed the remaining shortfall in its renounceable rights issue, raising a total of $1.3 million to advance its cellular immunotherapy pipeline. The company also addressed an administrative breach involving director share allocations, ensuring compliance with ASX rules.